Alloy Review
Best for: Menopause Society-certified care with the broadest GLP-1 formulary
Alloy is a menopause-focused telehealth brand whose Weight Care program runs the broadest GLP-1 formulary in our catalog — brand Wegovy, brand Zepbound, oral Wegovy, plus compounded semaglutide, tirzepatide and liraglutide. Every consulting doctor is certified by The Menopause Society. Pricing spans brand Wegovy from $199/mo to compounded liraglutide from $80/mo, with a $49 initial consult and a STARTGLP1 promo for $50 off the first month.
No insurance needed · Vetted by our editors
WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Learn more
The Bottom Line
Alloy is a solid telehealth option with balanced features and pricing.
Alloy at a glance
- Type
- GLP-1 telehealth provider
- Medications
- Semaglutide, Tirzepatide, Liraglutide, Wegovy, Zepbound
- Starting price
- $169/mo ($70 medication + mandatory $99/mo Alloy Weight Care fee = $169/mo effective)
- FDA status
- No FDA warning letter on record
How we scored Alloy
Each dimension is scored algorithmically from Alloy’s real pricing, drugs offered, verification status, and disclosed inclusions — using the same six-dimension framework we apply to every provider.
Value25%
7.4/10At $169/mo, Alloy runs in line with the $170 median for GLP-1 providers.
Effectiveness25%
8.6/10Alloy offers both semaglutide and tirzepatide — the two GLP-1 molecules with the strongest published weight-loss trial outcomes. FDA-approved brand options are available alongside compounded versions. An oral/needle-free option is offered for patients who avoid injections.
User Experience15%
7.3/10Online intake and platform experience; 8 platform features disclosed.
Trust & Safety15%
7.1/10Core details confirmed by our editors; no FDA warning letters on file (last checked 2026-06-06).
Accessibility10%
6.2/10Alloy's exact state footprint isn't published — confirm coverage in your state before signing up.
Support10%
6.0/10Alloy provides standard clinician follow-up; no extended coaching or community program is disclosed.
How we verified this Alloy review
Last checked 2026-06-06- Confirmed current pricing across 5 dose/plan tiers
- Checked the FDA warning-letter database for enforcement actions
- Walked the public intake/checkout flow on the provider's site
Pricing, availability, and compliance facts come from the provider's own site and primary regulatory records — see the sources below. Editorial confidence in this data: medium.
GLP-1 medications Alloy offers
Tap any medication to read our plain-English guide — how it works, dosing, side effects, and what the trials found.
Pricing
$70 medication + mandatory $99/mo Alloy Weight Care fee = $169/mo effective
$100 medication + mandatory $99/mo Alloy Weight Care fee = $199/mo effective
$115 medication + mandatory $99/mo Alloy Weight Care fee = $214/mo effective
$199-$499 medication + mandatory $99/mo Alloy Weight Care fee; $298/mo effective at the $199 starting dose
$299 medication + mandatory $99/mo Alloy Weight Care fee = $398/mo effective
Ready to get started?
Plans and promotions change often — check Alloy's current pricing and active discounts before you decide.
What we like
- Broadest GLP-1 formulary here: brand Wegovy and Zepbound, oral Wegovy, plus compounded semaglutide, tirzepatide, and liraglutide
- All consulting doctors are certified by The Menopause Society — a rare credential
- STARTGLP1 promo code takes $50 off the first month
- Spans the price range: compounded semaglutide from $70/mo, brand Wegovy from $199/mo (each plus the $99/mo Weight Care fee)
Watch-outs
- Menopause-focused — best for women in menopause or perimenopause, not men or younger patients
- A mandatory $99/mo Alloy Weight Care fee sits on top of every medication price (so the true minimum is ~$169/mo, not $70)
- Compounded semaglutide not available in AL, AR, CA, NV, LA, MS or DC
Alloy: a menopause clinic that happens to run the widest GLP-1 menu we've seen
Most GLP-1 telehealth brands are weight-loss companies first. Alloy is the opposite — it's a menopause care company, founded by Anne Fulenwider and Monica Molenaar, that added a Weight Care program for the same women it already treats for hot flashes, sleep, and hormone changes. That framing is the whole point. If you're a woman in perimenopause or menopause who wants weight care from a doctor who actually understands what your body is doing right now, Alloy is built for you in a way almost no general GLP-1 clinic is. If you're a man, or a younger patient, or someone who just wants the cheapest possible vial of compounded medication, this isn't your provider — and that's worth saying up front.
Every consulting doctor is certified by The Menopause Society
This is Alloy's real differentiator, not a marketing line. The clinicians who review your case are certified by The Menopause Society, most with a decade or more of experience. That's a genuinely rare credential in this space — the typical GLP-1 startup routes you to a general telehealth provider who's fine but not specialized. For a patient whose weight gain is tangled up with menopause, having a prescriber who treats that intersection every day is the kind of thing that's hard to put a price on and easy to undervalue until you've sat across from a doctor who doesn't get it.
The broadest formulary in our catalog — brand, oral, and three compounded options
Alloy offers more GLP-1 choices than any other provider we rank. You can get brand-name Wegovy and brand-name Zepbound, oral Wegovy (the semaglutide pill), and compounded semaglutide, tirzepatide, and liraglutide. Practically, that means you and your doctor aren't boxed into one molecule. If compounded semaglutide doesn't agree with you, there's a path to tirzepatide; if you want the FDA-approved brand product and can absorb the higher cost, that door is open too. Most clinics offer one or two of these. Alloy offers all of them under one roof.
- Brand: Wegovy and Zepbound (FDA-approved, manufacturer products)
- Oral: Wegovy semaglutide pill for needle-averse patients
- Compounded: semaglutide, tirzepatide, and liraglutide
How the pricing really works: medication plus a mandatory membership
Here's the part you need to read carefully, because Alloy's own pages can make it look cheaper than it is. The medication has one price and the program has another. On top of every prescription sits a mandatory monthly Alloy Weight Care fee, and you pay both. The cheapest medication on the menu is compounded semaglutide, but once you add the required Weight Care fee, the true floor a patient actually pays lands at about $169 a month — which is essentially in line with the category median of $170. So when you see a low headline number on a product page, mentally add the membership before you compare it to anyone else.
The brand options climb from there: brand Wegovy starts in the low-to-mid hundreds for the medication before the fee, and brand Zepbound starts higher still, with the membership stacked on top of each. There is a first-month promotional discount for new customers via a code, but Alloy doesn't run a deep teaser rate that resets to a much higher bill later — what you pay in month two is roughly what you'll keep paying.
What that monthly Weight Care fee actually buys
To be fair to Alloy, the membership isn't a junk fee — it's the support model. Per Alloy's own description, it covers unlimited messaging with your menopause-specialized doctor, wellness check-ins, side-effect management, dose adjustments, and long-term planning, plus free delivery to your door. For a patient who wants a real ongoing relationship and hand-holding through dose titration and side effects, that's reasonable value. For a patient who just wants a low-touch refill and doesn't plan to message anyone, it's a cost that's hard to escape, because it isn't optional.
Where Alloy is and isn't available
Alloy ships to most of the country — roughly 48 states — but Louisiana and Mississippi are explicitly excluded. Compounded semaglutide specifically carries a longer exclusion list: it isn't available in Alabama, Arkansas, California, Nevada, Louisiana, Mississippi, or Washington, D.C. If you live in one of those states and had your heart set on compounded semaglutide, check the other formulary options or confirm directly before you sign up.
Trust and safety
On the oversight side, Alloy holds up well. We found no FDA warning letters and no litigation tied to the brand. Combine that clean record with the Menopause Society credential and transparent — if slightly buried — pricing, and this is a provider we're comfortable rating in the middle-to-upper tier for trust. The main honesty flag isn't safety; it's that two-part pricing that can understate the real cost. Read how we weigh these factors in our scoring methodology.
Who should choose Alloy, and who should skip it
- Choose it if you're a woman in peri/menopause who wants weight care from a doctor who specializes in exactly that life stage, and you value having every GLP-1 option on the table.
- Choose it if you want an ongoing, message-your-doctor relationship and will actually use the support the membership pays for.
- Skip it if you're a man or a younger patient outside Alloy's core focus — this care is built around menopause.
- Skip it if you want the absolute lowest sticker price; the mandatory Weight Care fee means the cheapest vial isn't really the cheapest plan.
Bottom line
Alloy is a specialist wearing a weight-loss hat, and that's its strength. For the right patient — a woman navigating menopause who wants a credentialed doctor and the freedom to pick from the widest drug menu we rank — it's an easy recommendation, with effective pricing around $169 that sits right at the category median once you account for everything. Just go in clear-eyed about the mandatory membership: the medication price you see on the page is never the whole bill, and the value of that fee depends entirely on whether you'll use the support it buys.
For a side-by-side, Sunlight ($159/month) and Bodybuilding Health+ ($179/month) are the most comparable options to weigh against Alloy.
Ready to start with Alloy?
Starting at $169/month. See current pricing and start your free consultation.
Alloy might not be your best fit if…
We rank editorially, so here’s where a different provider we track may serve you better.
Alternatives to Alloy
Enhance MD
Best for: lab-monitored compounded GLP-1 with mandatory video visit
Editorial score · methodology
Editorial score · methodology
Editorial score · methodology
Frequently Asked Questions
Key terms, explained
New to GLP-1s? Tap any term for a quick, plain-English definition.
- Semaglutide · Drugs and brands
- Tirzepatide · Drugs and brands
- Compounded GLP-1 · Pharmacy and drug forms
- 503A pharmacy · Pharmacy and drug forms
- PCAB accreditation · Pharmacy and drug forms
- Prior authorization (PA) · Insurance and regulatory
- Off-label use · Insurance and regulatory
- FDA Drug Shortage List · Insurance and regulatory
Sources
The primary regulatory filings and peer-reviewed studies cited throughout this Alloy review:
Sources & methodology — as of July 2026
- 1.Weight Loss Rankings — GLP-1 Pricing Index 2026 (our independent dataset)— WeightLossRankings.org.
- 2.FDA — Compounding and the 503A Pharmacy Framework— U.S. Food & Drug Administration.
- 3.FDA — Drug Shortages Database (current shortage listings)— U.S. Food & Drug Administration.
- 4.PCAB — Pharmacy Compounding Accreditation Board Standards— Accreditation Commission for Health Care (ACHC) / PCAB.
- 5.KFF — Medicaid coverage research (anti-obesity & GLP-1 drug policy)— Kaiser Family Foundation.
- 6.STEP 1 Trial — Once-Weekly Semaglutide in Adults with Overweight or Obesity (Wilding JPH et al.)— New England Journal of Medicine.PMID: 33567185.
- 7.FDA — Wegovy (semaglutide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 8.FDA — Ozempic (semaglutide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
- 9.SURMOUNT-1 Trial — Tirzepatide Once Weekly for the Treatment of Obesity (Jastreboff AM et al.)— New England Journal of Medicine.PMID: 35658024.
- 10.FDA — Zepbound (tirzepatide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 11.FDA — Mounjaro (tirzepatide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
- 12.SURMOUNT-5 Trial — Tirzepatide vs. Semaglutide Head-to-Head in Obesity (Garvey WT et al.)— New England Journal of Medicine.PMID: 40334173.
Ready to start with Alloy?
Starting at $169/month. See current pricing and start your free consultation.